![Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes](https://www.g2intelligence.com/wp-content/uploads/2023/03/March15-2023.News_.WeeklyEnforcementReport-DrugTesting-Scam-iStock-1327475879_1800x1250-1080x675.jpg)
Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
In this webinar, our expert speakers will share what the end of the COVID-19 PHE will mean for clinical labs and how they can best prepare.
With COVID-19 testing demand all but dried up, labs will have to make—or at least contemplate making—significant changes to their business.
Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.
Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.